Farmmi, Inc. (FAMI) 股票分析

公司概述

Farmmi, Inc. primarily engages in the processing and sale of agricultural products, specifically focusing on edible fungi such as Shiitake mushrooms, Mu Er mushrooms, bamboo fungi, agrocybe aegerila, and pleurotus across international markets including China, the United States, Japan, Canada, Europe, Korea, and the Middle East. The company operates within the Consumer Defensive sector and the Packaged Foods industry, positioning itself as a provider of essential food items that typically exhibit lower price elasticity compared to discretionary spending categories. As a micro-cap entity, Farmmi, Inc. maintains a market capitalization of $16.85 million and employs a workforce of 15 individuals to support its global distribution network. The combination of a relatively small market cap and annual revenue of $27.97 million indicates that the company operates on a niche scale, likely serving specific distribution channels or regional markets rather than competing directly with large-scale domestic food conglomerates.

财务健康

The company reported a trailing twelve-month (TTM) revenue of $27.97 million, yet this generated a net income of -$53,098,648, revealing a severe disconnect where operating expenses and losses far exceed total sales. This substantial gap between revenue and net income suggests an extremely fragile cost structure where fixed costs or one-time charges have overwhelmed the company's ability to generate profit from its core sales activities. Despite the negative net income, the firm reports a free cash flow of $43.90 million, which provides a degree of financial flexibility by allowing the company to potentially cover operational outflows or service debt obligations without immediate reliance on external equity financing. However, the gross margin stands at only 2.9%, indicating that the company retains very little revenue after the direct costs of producing its agricultural products. Furthermore, the operating margin is a negative 393.8% and the profit margin is -189.8%, figures that confirm the business is currently unprofitable on an operational and bottom-line basis. In terms of leverage, the company holds $803,477 in cash against $20.77 million in debt, resulting in a debt-to-equity ratio of 16.77, which characterizes a highly leveraged balance sheet rather than a conservative one. The current ratio is 9.35, suggesting that the company possesses ample short-term liquid assets relative to its current liabilities, though this liquidity does not mitigate the underlying debt burden. Additionally, the return on equity is -36.3% and the return on assets is -17.7%, metrics that indicate management has not been effective in generating positive returns for shareholders or utilizing assets to create value during this reporting period.

估值评估

The P/E Ratio (TTM) and Forward P/E are both listed as N/A, reflecting the absence of normalized earnings due to the company's significant net losses and negative profitability trajectory. The price-to-book ratio is 0.05, which indicates that the market values the company at a fraction of its net asset book value, suggesting a deep discount often associated with distressed assets or companies with negative equity adjustments. While the P/E multiples are unavailable, the price-to-sales ratio is 0.60, an alternative valuation metric that suggests the market prices the stock at less than one-third of its annual sales, potentially reflecting skepticism regarding future revenue sustainability. The EV/EBITDA stands at -0.78, a negative figure that precludes traditional enterprise value comparisons but highlights the company's negative cash generation relative to its enterprise value. The stock has traded between a 52-week low of $1.11 and a 52-week high of $2.22, meaning the current price sits somewhere within this historical range, bounded by these extremes. The beta is 1.65, which signifies that the stock's price volatility is significantly higher than that of the broader market, making it more sensitive to systemic market movements and investor sentiment shifts.

Growth & Income

The revenue growth year-over-year is -57.3%, while the earnings growth is N/A due to the lack of positive earnings in the prior period for comparison. The contraction in revenue indicates a significant decline in sales volume or pricing power, and without positive earnings, the comparison of earnings growth to revenue growth is not applicable in a traditional sense. As the company does not pay dividends, the dividend yield is N/A and the payout ratio is 0.0%, meaning the firm retains all its minimal earnings and does not distribute cash to shareholders. Consequently, the company reinvests its resources, if any, back into operations rather than providing income streams for investors. The overall growth and income profile is characterized by declining sales, negative profitability, and an absence of dividend distribution, presenting a challenging fundamental picture for income-oriented or growth-seeking investors.